Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Feb;39(2):556–558. doi: 10.1128/aac.39.2.556

Inhibition of duck hepatitis B virus DNA replication by antiviral chemotherapy with ganciclovir-nalidixic acid.

Y Wang 1, C Luscombe 1, S Bowden 1, T Shaw 1, S Locarnini 1
PMCID: PMC162580  PMID: 7726533

Abstract

The aim of this study was to examine the effects of ganciclovir and nalidixic acid either alone or in combination on duck hepatitis B virus DNA replication in vivo with particular reference to production of viral supercoiled DNA and RNA. The most effective antiviral response was observed in the livers of ducks treated by the combination therapy for 28 days, which resulted in a substantial decrease in the amounts of viral supercoiled DNA, relaxed circular and single-stranded DNA, and also viral RNA. This combination treatment was not hepatotoxic over the study period.

Full Text

The Full Text of this article is available as a PDF (188.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander G. J., Brahm J., Fagan E. A., Smith H. M., Daniels H. M., Eddleston A. L., Williams R. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet. 1987 Jul 11;2(8550):66–69. doi: 10.1016/s0140-6736(87)92735-8. [DOI] [PubMed] [Google Scholar]
  2. Civitico G. M., Locarnini S. A. The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures. Virology. 1994 Aug 15;203(1):81–89. doi: 10.1006/viro.1994.1457. [DOI] [PubMed] [Google Scholar]
  3. Civitico G., Wang Y. Y., Luscombe C., Bishop N., Tachedjian G., Gust I., Locarnini S. Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds. J Med Virol. 1990 Jun;31(2):90–97. doi: 10.1002/jmv.1890310205. [DOI] [PubMed] [Google Scholar]
  4. Fan-Havard P., Nahata M. C., Brady M. T. Ganciclovir--a review of pharmacology, therapeutic efficacy and potential use for treatment of congenital cytomegalovirus infections. J Clin Pharm Ther. 1989 Oct;14(5):329–340. doi: 10.1111/j.1365-2710.1989.tb00256.x. [DOI] [PubMed] [Google Scholar]
  5. Hirota K., Sherker A. H., Omata M., Yokosuka O., Okuda K. Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection. Hepatology. 1987 Jan-Feb;7(1):24–28. doi: 10.1002/hep.1840070107. [DOI] [PubMed] [Google Scholar]
  6. Jilbert A. R., Freiman J. S., Burrell C. J., Holmes M., Gowans E. J., Rowland R., Hall P., Cossart Y. E. Virus-liver cell interactions in duck hepatitis B virus infection. A study of virus dissemination within the liver. Gastroenterology. 1988 Nov;95(5):1375–1382. doi: 10.1016/0016-5085(88)90375-7. [DOI] [PubMed] [Google Scholar]
  7. Kassianides C., Hoofnagle J. H., Miller R. H., Doo E., Ford H., Broder S., Mitsuya H. Inhibition of duck hepatitis B virus replication by 2',3'-dideoxycytidine. A potent inhibitor of reverse transcriptase. Gastroenterology. 1989 Nov;97(5):1275–1280. doi: 10.1016/0016-5085(89)91699-5. [DOI] [PubMed] [Google Scholar]
  8. Korenman J., Baker B., Waggoner J., Everhart J. E., Di Bisceglie A. M., Hoofnagle J. H. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med. 1991 Apr 15;114(8):629–634. doi: 10.7326/0003-4819-114-8-629. [DOI] [PubMed] [Google Scholar]
  9. Kreuzer K. N. DNA topoisomerases as potential targets of antiviral action. Pharmacol Ther. 1989;43(3):377–395. doi: 10.1016/0163-7258(89)90017-x. [DOI] [PubMed] [Google Scholar]
  10. Lee B., Luo W. X., Suzuki S., Robins M. J., Tyrrell D. L. In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus. Antimicrob Agents Chemother. 1989 Mar;33(3):336–339. doi: 10.1128/aac.33.3.336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Locarnini S., Guo K., Lucas R., Gust I. Inhibition of HBV DNA replication by ganciclovir in patients with AIDS. Lancet. 1989 Nov 18;2(8673):1225–1226. doi: 10.1016/s0140-6736(89)91839-4. [DOI] [PubMed] [Google Scholar]
  12. Luscombe C., Pedersen J., Bowden S., Locarnini S. Alterations in intrahepatic expression of duck hepatitis B viral markers with ganciclovir chemotherapy. Liver. 1994 Aug;14(4):182–192. doi: 10.1111/j.1600-0676.1994.tb00072.x. [DOI] [PubMed] [Google Scholar]
  13. Shaw T., Amor P., Civitico G., Boyd M., Locarnini S. In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus. Antimicrob Agents Chemother. 1994 Apr;38(4):719–723. doi: 10.1128/aac.38.4.719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sherker A. H., Hirota K., Omata M., Okuda K. Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks. Gastroenterology. 1986 Oct;91(4):818–824. doi: 10.1016/0016-5085(86)90681-5. [DOI] [PubMed] [Google Scholar]
  15. Summers J., Mason W. S. Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate. Cell. 1982 Jun;29(2):403–415. doi: 10.1016/0092-8674(82)90157-x. [DOI] [PubMed] [Google Scholar]
  16. Tagawa M., Omata M., Okuda K. Appearance of viral RNA transcripts in the early stage of duck hepatitis B virus infection. Virology. 1986 Jul 30;152(2):477–482. doi: 10.1016/0042-6822(86)90151-0. [DOI] [PubMed] [Google Scholar]
  17. Thomas H. C., Lever A. M., Scully L. J., Pignatelli M. Approaches to the treatment of hepatitis B virus and delta-related liver disease. Semin Liver Dis. 1986 Feb;6(1):34–41. doi: 10.1055/s-2008-1040791. [DOI] [PubMed] [Google Scholar]
  18. Wu T. T., Coates L., Aldrich C. E., Summers J., Mason W. S. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology. 1990 Mar;175(1):255–261. doi: 10.1016/0042-6822(90)90206-7. [DOI] [PubMed] [Google Scholar]
  19. Yokosuka O., Omata M., Imazeki F., Okuda K., Summers J. Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA. Hepatology. 1985 Sep-Oct;5(5):728–734. doi: 10.1002/hep.1840050505. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES